Financials

News Ideas Forecast

YB3 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Shin Nippon Biomedical Laboratories Ltd.

Total assets of YB3 for Q4 23 is 467.22 M EUR, 1.95% more than the previous Q3 23. And total liabilities decreased by 2.26% in Q4 23 to 258.04 M EUR.

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: EUR

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—